Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Grammy nominations 2026: Full list of nominees in every major category, including Album of the Year and Best New Artist - 2Virtual Route d: A Survey of \Exploring On the web Stages\ Web Administration
- 3She just became the first wheelchair user to travel to space
- 4Worldwide Objections Ideal For A Golf Outing
- 5'We are ready': NASA still on track to launch Artemis 2 astronauts to the moon April 1
- Humpback whale stranded on Germany's Baltic coast frees itself
- Porsche May Kill the Electric Boxster Before It Ever Arrives
- The Electric Bicycle Americans Can Confide in 2024
- Manual for Individual accounting Rudiments for Fledglings
- The Universe of Impeccable Pearls: A Manual for Valuable Gems
- Cygnus XL brings cargo to the ISS for 1st time | Space photo of the day for Dec. 1, 2025
- Vote In favor of Your Favored Occasion Arranging Administration
- At least 11 killed in South Africa mass shooting
- Audits of Espresso Types: Which Mix Is for You?
